Trower Paul
SEC CIK 1642041 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | Principal Accounting Off | 39.1K | — | $602.2K | 4 | 2021-07-02 | 2022-01-03 |
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
Trower Paul made no open-market trades at INCY in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-05 | 2022-01-03 | INCY | Incyte | Trower Paul | Principal Accounting Off | M - OptEx | $73.21 | +8,214 | 39.1K | +27% | +$601.3K |
| DM | 2022-01-05 | 2022-01-03 | INCY | Incyte | Trower Paul | Principal Accounting Off | S - Sale+OE | $73.31 | -8,214 | 32.3K | -20% | -$602.2K |
| D | 2021-07-07 | 2021-07-02 | INCY | Incyte | Trower Paul | Principal Accounting Off | A - Grant | $0.00 | +4,521 | 33.2K | +16% | $0 |
| DM | 2021-07-07 | 2021-07-02+ | INCY | Incyte | Trower Paul | Principal Accounting Off | F - Tax | $83.55 | -976 | 32.4K | -3% | -$81.5K |
Purchase Sale Sale after option exercise All abbreviations